IMPORTANCE Population-based studies on the prevalence of symptoms after Roux-en-Y gastric bypass (RYGB) surgery are sparse. Knowledge about possible predictors of these symptoms is important for prevention.
F or patients with morbid obesity, bariatric surgery, including Roux-en-Y gastric bypass (RYGB) surgery, is an effective treatment for weight loss and diseases associated with obesity. 1, 2 However, various medical, nutritional, and surgic al symptoms requiring treatment may occur after RYGB surgery [3] [4] [5] and may impair patients' quality of life (QoL). These symptoms have generally been classified as surgical or medical and nutritional depending on the primary treatment procedures. Common surgical symptoms after RYGB surgery include gallstones (7%-16% after 18-26 months' follow-up) 6, 7 and kidney stones (≤8% after 19-42 months' follow-up). 8 Well-known medical and nutritional symptoms include dumping syndrome (12%-42% after 1-2 years), [9] [10] [11] hypoglycemia (0.2% of patients were hospitalized within 0-20 years), 12 diarrhea (18% of patients with anal leakage of stool potentially provoked by diarrhea after 2 years), 13 peripheral neuropathy (16% of patients, with unknown follow-up period), 14 and anemia (23%-47% after 24-48 months). [15] [16] [17] Commonly observed symptoms in clinical practice, such as abdominal pain and fatigue, are sparsely described in the literature on RYGB surgery despite the importance of such symptoms for patients' functional status and QoL. 18, 19 Thus, a large population-based study with long-term follow-up of patients who had undergone RYGB surgery, providing a more comprehensive examination of symptom prevalence, is warranted.
Knowledge of possible predictors is important to prevent symptoms related to RYGB surgery after the procedure. Most patients undergoing RYGB surgery are women; recent studies have pointed toward a higher risk of hospitalization after RYGB surgery for women than for men, 20, 21 whereas others have found no influence of sex on the rate of hospitalization after the procedure. 22 Furthermore, advanced age has been associated with increased risk of hospitalization after surgery. 20, 21, 23 Increased mortality and morbidity after other types of surgery has been observed for smokers, 24 unmarried patients, 25 and unemployed persons. 26 Whether such demographic and lifestyle factors also predict symptoms after bariatric surgery, to our knowledge, have not yet been examined.
Previous studies have reported improved physical QoL but not mental QoL after bariatric surgery. 27, 28 The influence of medical and nutritional symptoms on QoL after RYGB surgery has, to our knowledge, not been examined previously. As surgical symptoms have been associated with reduced QoL, 29 we hypothesized that patients with medical and nutritional symptoms following RYGB surgery have a poorer QoL than do patients with no symptoms.
We aimed to conduct a comprehensive study of the wellbeing and the severity and burden of common symptoms after RYGB surgery. Furthermore, we examined possible predictors of symptoms requiring health care contact after RYGB surgery, including demographic, clinical, socioeconomic, and lifestyle factors. Finally, we examined the association of medical, nutritional, and surgical symptoms with QoL after RYGB surgery.
Methods

Setting
The Central Denmark Region has a population of approximately 1.27 million people. All residents are registered in the Civil Registration System (CRS) and assigned a unique personal identification number (CRS number). 30, 31 The Danish National Board of Health provides tax-supported health care, including RYGB surgery. In Denmark, all patients must be seen by the general practitioner to be referred to secondary care (outpatient and inpatient clinics or hospitalization). 32
Participants
We obtained CRS numbers for all 3121 patients undergoing RYGB surgery (International Classification of Diseases, 10th Revision, codes KJDF10 [gastric bypass] and KJDF11 [laparoscopic gastric bypass]) within Central Denmark between January 1, 2006, and December 31, 2011 (>99% of the operations were laparoscopic RYGB surgery). The CRS provided data on the vital status of all patients. Patients who were deceased (n = 32), had emigrated (n = 14), had unknown vital status (n = 1), had a CRS-registered restriction against researcher inquiries (n = 791), or were unknown at their registered address (n = 45) were excluded (eFigure 1 in the Supplement). The study questionnaire was mailed to 2238 eligible patients on March 3, 2014. Two reminders were sent to those who did not respond. On June 8, 2015, a comparison cohort of 89 individuals who did not undergo RYGB surgery and who were matched with patients according to sex and body mass index were recruited via the Internet; this cohort also responded to the questionnaire.
According to Danish legislation, 33 questionnaire studies do not require a separate permission from the Danish Scientific Ethical Committee. Patients provided written consent to participate in the surveys.
Questionnaire
The questionnaire included items on sex, age, height, weight, preoperative surgical symptoms, cohabiting status, educational level, employment status, tobacco smoking, surgical symptoms after RYGB surgery (abdominal pain [eg, leakage, herniation], kidney stones, and gallstones), and medical and nutritional symptoms after RYGB surgery (diarrhea, anemia, fatigue, neurologic symptoms, dumping, and hypoglycemia). Questions on hospitalizations owing to plastic surgery after RYGB surgery were not included. For each symptom that occurred after RYGB surgery, we asked patients if the symptom had led to any contact with the health care system, categorizing patients as follows: 1, no contact; 2, any contact (including contact with general practitioner, visit in outpatient specialty clinic, and hospital admission); 3, contact with secondary care only (visit in outpatient specialty clinic and hospital admission); and 4, hospital admission (eFigure 2 in the Supplement). Contacts with the health care system owing to routine follow-up visits after RYGB surgery were not included in this questionnaire. Presence of symptoms prior to RYGB surgery was also queried.
The Edinburgh Hypoglycemia Scoring System (18 questions) 34 and the Dumping Symptom Rating Scale (9 questions) 9 were included in the questionnaire. The 2 scales are Likert scales, both ranging from 1 to 7. For hypoglycemia and dumping (general and gastrointestinal symptoms after gastrectomy), the severity of the symptoms and health-seeking behavior were estimated from a scoring system, in contrast with the other symptoms. We defined mild hypoglycemia as a score of 36 to 71 (symptomatic to the patient), moderate hypoglycemia as a score of 72 to 89 (likely to lead to contact with primary care), and severe hypoglycemia as a score of 90 or more (likely requiring contact with secondary care). We defined mild dumping as a score of 18 to 35 (symptomatic to the patient), moderate dumping as a score of 36 to 44 (likely to lead to contact with primary care), and severe dumping as a score of 45 or more (likely to lead to contact with secondary care).
We assessed QoL using the Mental Composite score (MCS) (6 items) and the Physical Composite score (PCS) (6 items) of the 12-Item Short-Form Health Survey (SF-12), which has been validated in the general Danish population. 35 The scores for all items are summed and transformed into a scale from 0 to 100 (0 indicates poorest possible health state; 100, best possible health state). A score below 50 indicates poor mental or physical health. The SF-12 scores were calculated using Health Outcome Scoring Software, version 4.5 (Optum Inc). We also included a question addressing current well-being compared with well-being before RYGB surgery.
Statistical Analysis
Data analysis was conducted from September 1, 2014, to June 25, 2015. We tabulated characteristics of the cohort that underwent RYGB surgery and the comparison cohort and tabulated the prevalence and severity of symptoms. For the cohort that underwent RYGB surgery, we computed the prevalence and the unadjusted and adjusted prevalence ratios (PRs) of symptoms, comparing possible predictors of symptoms leading to any health care contact, using Poisson regression analysis. The variables predefined as possible predictors were sex (male or female), age (<35 years, 35-44 years, or ≥45 years), surgical symptoms before RYGB surgery (abdominal pain, kidney stones, or gallstones), cohabiting status (living with someone or living alone), educational level (≤9 years, 10-12 years, or >12 years), employment status (full time, part time, or unemployed), and tobacco smoking (yes or no). All PRs were adjusted for demographic (age and sex), clinical (preoperative BMI, percentage weight loss, and surgical symptoms before RYGB surgery), socioeconomic (cohabiting status, employment status, and educational level), and lifestyle (smoking) fac- 
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Prevalence of Self-reported Symptoms After Gastric Bypass Surgery tors. We conducted stratified analyses of prevalence and PRs focusing on medical and nutritional symptoms alone (diarrhea, fatigue, anemia, neurologic symptoms, hypoglycemia, and dumping), surgical symptoms alone (abdominal pain, kidney stones, and gallstones), and symptoms requiring hospitalization. We presented graphically the overall well-being of patients who underwent RYGB surgery and calculated symptom prevalence according to this factor. Patients who underwent RYGB surgery were grouped according to the number of symptoms leading to health care contact (0, 1, 2, 3, ≥4 symptoms). The median score and interquartile range (IQR) of the PCS and the MCS were calculated for each group as data were nonnormally distributed. We calculated the Spearman rank correlation coefficient (r) for the correlations between MCS and PCS and SF-12 scores.
Statistical analyses were performed using STATA, version 13.0 (StataCorp LP). The study was approved by the Danish Data Protection Agency.
Results
A total of 1429 patients undergoing RYGB surgery (63.7%) responded to the survey; 286 (20.0%) were male. Median time since RYGB surgery was 4.7 years. Mean age at the time of the survey was 47.1 years (range, 26.9-68.0 years); the current median body mass index (calculated as weight in kilograms divided by height in meters squared) was 29.7, corresponding to a median total weight loss of 35.7%. As seen in Table 1 , the comparison cohort was matched on current body mass index (29.4) and sex (22.5% male), yet it was slightly younger (mean age, 37.7 years).
Prevalence of Symptoms After RYGB Surgery
A total of 1266 patients (88.6%) who underwent RYGB surgery reported 1 or more symptoms ( . We estimated that 130 patients (9.1%) were likely to have health care contact owing to dumping and 95 (6.6%) owing to hypoglycemia. Dumping and hypoglycemia alone accounted for only 24 (1.7%) of the total health care contacts.
Inpatient hospitalizations owing to any symptom after surgery were reported by 416 patients (29.1%) in those who underwent RYGB surgery vs 6 individuals (6.7%) in the compari- Stratification for medical and nutritional symptoms and surgical symptoms after RYGB surgery provided results that were consistent with the results of all symptoms combined, with some exceptions. More women had medical and nutritional symptoms (PR, 1.45; 95% CI, 1.24-1.69). For surgical symptoms, the sex difference was smaller (PR for women, 1.15; 95% CI, 0.98-1.34), but the association with surgical symptoms before RYGB surgery was strong (PR, 1.93; 95% CI, 1.74-2.14). Concerning analysis restricted to hospitalizations, results were similar except for higher PRs for patients who underwent RYGB surgery and experienced a large amount of postoperative weight loss (PR for weight loss ≥35%, 1.53; 95% CI, 1.29-1.82) and for those with surgical symptoms before RYGB surgery (PR, 1.75; 95% CI, 1.48-2.07) (eTable 1 in the Supplement).
Well-being After RYGB Surgery
In total, 1219 of 1394 (87.4%) patients felt better or much better and 113 (8.1%) reported reduced well-being after RYGB surgery (Figure) . Those 
Quality of Life
Based on the SF-12, the median MCS was 41.8 (IQR, 34.8-45.9) for patients who underwent RYGB surgery and 39.7 (IQR, 31.7-44.7) in the comparison cohort. The median PCS was 53.0 (IQR, 46.1-55.4) and 53.5 (IQR, 49.4-55.2), respectively. For patients who underwent RYGB surgery and experienced no symptoms, the median MCS was 44.1 and the median PCS was 54.2 compared with a median MCS of 33.6 and a median PCS of 45.0 for those with 4 or more symptoms. The Spearman rank correlation coefficients between number of symptoms and MCS and PCS were ρ = -0.30 and ρ = -0.23, respectively ( Table 4 ).
Discussion
Our study showed that 87.4% of the patients reported that they felt better after RYGB surgery. Nevertheless, 88.6% of patients reported 1 or more symptoms (mild to severe) a median of 4.7 years after RYGB surgery. In the comparison cohort, 78.7% of the participants reported symptoms, indicating that mild symptoms are a part of "normal" physiological features in pa-tients with obesity. Approximately two-thirds of patients who underwent RYGB surgery had health care contact owing to symptoms and 29.1% had been hospitalized, 79.0% owing to surgical symptoms and 21.0% owing to medical symptoms, a higher percentage than previously reported. 21 The patients who underwent RYGB surgery were hospitalized 4-to 5-fold more than the comparison cohort. Predictors of symptoms included younger age, female sex, smoking, and unemployment. Finally, a higher number of symptoms was associated with lower health-related QoL and reduced well-being after RYGB surgery.
Most patients reported a better or much better well-being after surgery despite a high prevalence of symptoms. Those who reported worse well-being were characterized by a high prevalence of symptoms. Obesity is associated with reduced QoL, possibly owing to stigmatization, reduced mobility, and obesityrelated diseases. 27 Satisfaction with weight loss after RYGB surgery may outweigh some dissatisfaction with symptoms after surgery. Previous studies have focused on symptoms leading to hospitalization. 20, 22, 23 Morgan et al 20 found that 18% of patients were hospitalized after bariatric surgery (mean followup, 41 months) compared with 29.1% in our study. However, they did not report on anemia, neurologic complications, gallstones, kidney stones, fatigue, and diarrhea, which may explain this difference. Our study also revealed a high prevalence of symptoms requiring contact with a general practitioner, figures that, to our knowledge, have not been reported previously. Our results are consistent with the prevalences reported in studies regarding severe dumping, anemia, kidney stones, gallstones, and neurologic symptoms. [6] [7] [8] [9] [10] [11] [14] [15] [16] [17] [36] [37] [38] [39] Dumping may, however, be an integrated part of the effect of RYGB surgery in inducing weight loss. Because hypoglycemia consists of unspecific symptoms, patients with this condition might be overlooked or misdiagnosed. Prevalence estimates to date have been based on hospital admission data although many patients with hypoglycemia are not hospitalized. 12 In corroboration with the findings by Telem et al 21 and Morgan et al, 20 we identified a higher prevalence of symptoms among women. The discrepancy with Stroh et al, 22 who found no difference between sexes after adjustments, may be explained by anemia not being included in that study. In an additional analysis excluding anemia, we found that both the unadjusted and adjusted results were unchanged. In contrast to 3 previous studies, 20, 21, 23 we found that younger age was associated with a higher prevalence of symptoms. However, the results of those studies are not directly comparable. Those studies included different symptoms, 20,21,23 examined 30-day complication rates, 23 or only examined hospitalizations. 20, 21 After restricting our study to care received in the hospital, the association with younger age persisted (eTable 1 in the Supplement). We hypothesize that age may be an important factor in the conception of symptoms (ie, younger patients may accept fewer symptoms than older patients before contacting a physician).
We found that both cohorts had a reduced health-related QoL vs that of the comparison cohort, which is consistent with the results reported by Raoof et al. 40 We only measured the QoL after surgery and therefore were not able to identify changes in QoL. In those undergoing RYGB surgery, 955 of 1314 patients (72.7%) had an MCS below the cutoff for depression risk; in the comparison cohort, 66 of 85 individuals (77.6%) had an MCS below the cutoff for depression risk. 41 The negative effect of symptoms that occur after RYGB surgery on the patients' reported QoL suggests that screening for depression might be beneficial among patients undergoing RYGB surgery, especially among patients with several symptoms.
Since some of the symptoms (eg, diarrhea and fatigue) are common in the general population, we focused on symptoms leading to health care contact as indicators of symptom severity. All Danish patients undergoing RYGB surgery are offered 2 years of postoperative follow-up outpatient visits and then annual follow-up visits in primary care; there is a risk that patients will be unable to remember whether the visit was related to symptoms or simply a part of the postoperative follow-up program, which could lead to inaccurate reports on symptom-related visits. This risk does not apply for symptoms leading to hospitalization; these data were verified by data from the Danish National Patient Registry 42 on admissions owing to kidney stones and gallstones. We found satisfactory consistency between self-reported and registry-based data as described by a sensitivity and specificity greater than 0.80 (eTable 2 in the Supplement). 43 We assumed that these diagnoses were accurately remembered by the patients and were coded correctly.
The main strengths of our study are its large size, population-based sample, relatively long time frame, and examination of a broad range of symptoms and demographic factors. The size of our comparison cohort was rather small; however, the matching of the comparison cohort for sex and body mass index was good and we believe our comparisons reflect the prevalence of symptoms in overweight individuals . Another concern is that the questionnaire relied on selfreported symptoms elicited a long time after surgery. We did not ask about time relation between surgery and symptoms since we considered that to be a risk of misclassification and that recall bias would be large. The time elapsed since surgery also poses a risk of misclassification in answers concerning preoperative symptoms and weight. Furthermore, we had to construct cutoff points for hypoglycemia and dumping syndrome based on clinical knowledge, and not all scales have been validated exactly in the way we used them. 9, 34 The cutoff points we defined for dumping produced prevalence estimates consistent with those in the existing literature. Although our questions were comprehensive, focusing on the most common symptoms after RYGB surgery, we may have missed some symptoms. These often rare symptoms are, however, not expected to change the outcome.
Only 63.7% of patients completed the questionnaire. Nonrespondents tended to be younger, but the age distribution differed only by a few percentage points, not comprising a risk of bias (eTable 3 in the Supplement). More nonrespondents than respondents underwent RYGB surgery during 2010-2011, but there were no significant differences in PRs at time since surgery (eTable 4 in the Supplement). More of the nonrespondents were male; since male sex was associated with a lower risk of symptoms, we would expect an even larger sex difference than what we observed. It is possible that the respondents had symptoms that they were interested in addressing. At the same time, respondents satisfied with the results of their operation may have wished to report their satisfaction.
Conclusions
The vast majority of patients reported better or much better well-being after RYGB surgery. However, the amount of symptoms and health care contacts after RYGB surgery is rather high and represents a significant burden from an individual perspective as well as for society. Nearly one-third of patients had been admitted to a hospital owing to these symptoms, mainly surgical symptoms. Focus on the QoL among patients with many symptoms may be required since such patients are at risk of depression. Development of new weight loss treatments with less risk of subsequent symptoms should be a high priority.
